Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-136465

Published: 2020

Journal Articles

Novel Associations Between Mutations, Prognostic and Clinical Parameters in Untreated Progressive CLL: Data from E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group

Esteban Braggio, PhD, Victoria X Wang, Santiago Garcia, PhD, Laura Ann Bruins, Connie Lesnick, Jacqueline C. Barrientos, MD, Susan M. O'Brien, MD, Martin S. Tallman, MD, Rafael Fonseca, MD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2016) 128 (22): 4373.

https://doi.org/10.1182/blood.V128.22.4373.4373

Published: 2016

Journal Articles

The clinical applications of genome editing in HIV

Cathy X. Wang, Paula M. Cannon

Blood (2016) 127 (21): 2546–2552.

https://doi.org/10.1182/blood-2016-01-678144

Published: 2016

Journal Articles

Tipifarnib As Maintenance Therapy in Acute Myeloid Leukemia (AML) Improves Survival in a Subgroup of Patients with High Risk Disease. Results of the Phase III Intergroup Trial E2902

Selina Luger, MD, Victoria X Wang, Elisabeth Paietta, PhD, Rhett P. Ketterling, MD, Witold Rybka, MD, Hillard M. Lazarus, MD, Mark R Litzow, MD, Jacob M. Rowe, MD, Richard A. Larson, MD, Frederick R Appelbaum, MD, Martin S. Tallman, MD

Blood (2015) 126 (23): 1308.

https://doi.org/10.1182/blood.V126.23.1308.1308

Published: 2015

Journal Articles

Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells

Cathy X. Wang, Blythe D. Sather, Xuefeng Wang, Jennifer Adair, Iram Khan, Swati Singh, Shanshan Lang, Amie Adams, Gabrielle Curinga, Hans-Peter Kiem, Carol H. Miao, David J. Rawlings, Bruce E. Torbett

Blood (2014) 124 (6): 913–923.

https://doi.org/10.1182/blood-2013-12-546218

Published: 2014

Includes: Supplemental data

Journal Articles

Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor

Fouzia Amirache, Camille Lévy, Caroline Costa, Philippe-Emmanuel Mangeot, Bruce E. Torbett, Cathy X. Wang, Didier Nègre, François-Loïc Cosset, Els Verhoeyen

Blood (2014) 123 (9): 1422–1424.

https://doi.org/10.1182/blood-2013-11-540641

Published: 2014

Includes: Supplemental data

Journal Articles

More Frequent Hemoglobin Measurements and More Frequent Epoetin Alfa Titrations Are Both Associated with Increased Epoetin Alfa Dose but Not More Time in Target Hemoglobin Range,

T. Christopher Bond, PhD, Jaime Rubin, MA, Steven X Wang, MS, Alex Yang, MD

Blood (2011) 118 (21): 4194.

https://doi.org/10.1182/blood.V118.21.4194.4194

Published: 2011

Journal Articles

A Sensitive Molecular Method for Detection of Disseminating Hematopoietic Tumor Cells by Using Specific Epigenetic DNA Methylation Biomarkers

Michael X Wang, MD, PhD, Xiaohui Zhao, MD, PhD, Srilatha Nalluri, MS, Huan-You Wang, MD, PhD, Kristen H. Taylor, PhD, Huidong Shi, PhD, Charles W. Caldwell, MD, PhD

Blood (2008) 112 (11): 4850.

https://doi.org/10.1182/blood.V112.11.4850.4850

Published: 2008

Journal Articles

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

Ping-Ying Pan, George X. Wang, Bingjiao Yin, Junko Ozao, Teresa Ku, Celia M. Divino, Shu-Hsia Chen

Blood (2008) 111 (1): 219–228.

https://doi.org/10.1182/blood-2007-04-086835

Published: 2008

Journal Articles

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Marcos De Lima, X. Wang, P.F. Thall, D. Couriel, R.B. Jones, E.J. Shpall, U. Popat, S. Giralt, M. Korbling, R. Champlin, B.S. Andersson

Blood (2006) 108 (11): 322.

https://doi.org/10.1182/blood.V108.11.322.322

Published: 2006

Journal Articles

Detection of Minimal Residual Disease in Precursor B Lymphoblastic Leukemia (B-ALL) Patients by a Novel Epigenetic DNA Methylation Biomarker.

Michael X. Wang, MD, PhD, Deiter Duff, Huidong Shi, PhD, Kristen H. Taylor, PhD, Barbara A. Gruner, MD, Charles W. Caldwell, MD, PhD

Blood (2005) 106 (11): 4524.

https://doi.org/10.1182/blood.V106.11.4524.4524

Published: 2005

Journal Articles

Differential Antigenic Profile of High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Expressed by 11q23-Positive Acute Leukemia: An Immunotherapeutic Target.

Meir Wetzler, MD, M. T. Brady, BS, S. N.J. Siat, PhD, S. Kakati, PhD, A. W. Block, PhD, X. Wang, MD, PhD, S. P. Hunger, MD, A. J. Carroll, PhD, S. Ferrone, MD, PhD

Blood (2005) 106 (11): 3261.

https://doi.org/10.1182/blood.V106.11.3261.3261

Published: 2005

Journal Articles

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

William G. Wierda, MD, PhD, S. OBrien, MD, X. Wang, MS, A. Ferrajoli, MD, S. Faderl, MD, D. Thomas, MD, F. Ravandi, MD, K. Do, PhD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MD

Blood (2005) 106 (11): 5012.

https://doi.org/10.1182/blood.V106.11.5012.5012

Published: 2005

Journal Articles

Serum Beta-2 Microglobulin: The Universal Independent Prognostic Factor for Patients with CLL.

William G. Wierda, MD, PhD, X. Wang, MS, S. OBrien, MD, S. Faderl, MD, A. Ferrajoli, MD, D. Thomas, MD, F. Ravandi, MD, J. Cortes, MD, F. Giles, MD, C. Koller, MD, H. Kantarjian, MD, S. Lerner, MS, M. Keating, MB BS

Blood (2005) 106 (11): 5018.

https://doi.org/10.1182/blood.V106.11.5018.5018

Published: 2005

Journal Articles

Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.

Matthew W. Andres, DO, Robin A. Roberts, BS, Debbie J. Mustacich, PhD, Randy D. Gascoyne, MD, Deborah A. Fuchs, MD, Michael X. Wang, MD, Rita M. Braziel, MD, Wing C. Chan, MD, Thomas M. Grogan, MD, Lisa M. Rimsza, MD

Blood (2004) 104 (11): 4553.

https://doi.org/10.1182/blood.V104.11.4553.4553

Published: 2004

Journal Articles

Lymphocyte transfusion therapy for cancer patients [letter]

PD Boasberg, KM Tokita, PI Terasaki, X Wang

Blood (1996) 87 (8): 3522–3523.

https://doi.org/10.1182/blood.V87.8.3522.bloodjournal8783522

Published: 1996

NARROW

A Phase I Study of Anti-ICOS Antibody MEDI-570 for Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Angioimmunoblastic T-Cell Lymphoma (AITL) (NCI-9930)

Novel Associations Between Mutations, Prognostic and Clinical Parameters in Untreated Progressive CLL: Data from E1912, a Randomized Phase III Study of the ECOG-ACRIN Cancer Research Group

The clinical applications of genome editing in HIV

Tipifarnib As Maintenance Therapy in Acute Myeloid Leukemia (AML) Improves Survival in a Subgroup of Patients with High Risk Disease. Results of the Phase III Intergroup Trial E2902

Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells

Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor

More Frequent Hemoglobin Measurements and More Frequent Epoetin Alfa Titrations Are Both Associated with Increased Epoetin Alfa Dose but Not More Time in Target Hemoglobin Range,

A Sensitive Molecular Method for Detection of Disseminating Hematopoietic Tumor Cells by Using Specific Epigenetic DNA Methylation Biomarkers

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

Long-Term Follow-Up of IV Busulfan (Bu) with Fludarabine (Flu) vs IV Bu with Cyclophosphamide (Cy) as Pre (Allogeneic) Transplant Conditioning Therapy for AML/MDS.

Detection of Minimal Residual Disease in Precursor B Lymphoblastic Leukemia (B-ALL) Patients by a Novel Epigenetic DNA Methylation Biomarker.

Differential Antigenic Profile of High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Expressed by 11q23-Positive Acute Leukemia: An Immunotherapeutic Target.

Weighted Prognostic Models for Survival in Untreated and Previously Treated Patients with CLL.

Serum Beta-2 Microglobulin: The Universal Independent Prognostic Factor for Patients with CLL.

Gene Expression Profiling, Frozen and Paraffin Section Immunohistochemistry, and In Situ Hybridization for Determination of Monoclonality in Diffuse Large B-Cell Lymphoma.

Lymphocyte transfusion therapy for cancer patients [letter]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only